by RNA | Apr 20, 2022 | Client Success, Strategic Advisory, Valuation Advisory
By Jeff Williamson THE SITUATION: A healthcare company with a portfolio of products in development for treating cardiac conditions was fielding investor interest for a potential acquisition. The company wanted to weigh the relative merits of raising additional equity... Read More
by RNA | Apr 20, 2022 | Client Success, Valuation Advisory
By Jeff Suchocki, CFA The Situation: Adoption of ASC 842 – Lease Accounting is mandatory for all private companies for fiscal years beginning after December 15, 2021. To comply with this mandatory adoption requirement, a privately held, clinical stage biotech company... Read More
by RNA | Jul 20, 2021 | Client Success, Strategic Advisory
By Jeff Williamson THE SITUATION: A medical device company was preparing to launch a novel product used in interventional cardiac surgeries — one that offered improved performance, simplified clinical workflows, and reduced procedure times. The company asked... Read More
by RNA | Nov 10, 2020 | Client Success, Strategic Advisory, Valuation Advisory
THE PROBLEM: A healthcare technology company that sells its FDA 510(k) approved device and supporting dashboarding and analytic tools to hospitals was in the midst of a capital raising effort involving a one-on-one negotiation with an existing strategic partner. The... Read More
by RNA | Dec 13, 2019 | RNA Team News
Jeff Williamson has joined the RNA Advisors growing healthcare practice as Director. Mr. Williamson will focus on providing a greater breadth and depth of strategic advisory services to our healthcare, medical device, and life sciences clients. Mr. Williamson brings... Read More
